We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
7551
PUT
XPO
XPO
$23.7B
$29K ﹤0.01%
+2,891
New +$28.8K
ENFY
7552
DELISTED
Enlightify Inc
ENFY
$29K ﹤0.01%
833
-4
-0.5% -$155
QVCGB
7553
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$29K ﹤0.01%
24
LCI
7554
PUT
DELISTED
Lannett Company, Inc.
LCI
$29K ﹤0.01%
+200
New +$31K
TEN
7555
PUT
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$29K ﹤0.01%
500
-400
-44% -$23.1K
NPN
7556
DELISTED
Nuveen Pennsylvania Municipal Value Fund Common shares of beneficial interest
NPN
$29K ﹤0.01%
2,000
-2,000
-50% -$28.2K
SRF
7557
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$29K ﹤0.01%
322
-391
-55% -$35.1K
SSI
7558
DELISTED
Stage Stores Inc
SSI
$29K ﹤0.01%
+1,168
New +$24.8K
GNMX
7559
DELISTED
Aevi Genomic Medicine Inc
GNMX
$29K ﹤0.01%
4,144
+144
+4% +$1.13K
AVP
7560
CALL
DELISTED
Avon Products, Inc.
AVP
$29K ﹤0.01%
2,000
-5,000
-71% -$76.8K
GWR
7561
PUT
DELISTED
Genesee & Wyoming Inc.
GWR
$29K ﹤0.01%
300
-300
-50% -$28.4K
PCMI
7562
DELISTED
PCM, Inc
PCMI
$29K ﹤0.01%
2,935
+1,585
+117% +$16.1K
LDRH
7563
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$29K ﹤0.01%
836
+293
+54% +$8.69K
LF
7564
CALL
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$29K ﹤0.01%
3,800
-15,700
-81% -$115K
ADAT
7565
DELISTED
AUTHENTIDATE HOLDING CORP COM STK (DE)
ADAT
$29K ﹤0.01%
3,276
+942
+40% +$10.3K
TC
7566
CALL
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
$29K ﹤0.01%
13,200
+8,400
+175% +$21.2K
WX
7567
CALL
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$29K ﹤0.01%
800
+200
+33% +$7.34K
PGI
7568
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
$29K ﹤0.01%
2,390
+57
+2% +$648
MGAM
7569
CALL
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
$29K ﹤0.01%
1,000
+200
+25% +$6.3K
AXUT
7570
DELISTED
ISHARES TR MSCI ACWI EX US UTILITIES ETF
AXUT
$29K ﹤0.01%
624
+302
+94% +$13.4K
UN
7571
CALL
DELISTED
Unilever NV New York Registry Shares
UN
$29K ﹤0.01%
+700
New +$27.2K
DZK
7572
PUT
DELISTED
Direxion Daily Developed Markets Bull 3x Shares
DZK
$29K ﹤0.01%
400
+200
+100% +$14.1K
TYNS
7573
DELISTED
Direxion Daily 7-10 Year Treasury Bear 1X Shares
TYNS
$29K ﹤0.01%
876
-757
-46% -$25.2K
OREX
7574
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
$29K ﹤0.01%
450
-80
-15% -$5.41K
WWAV
7575
PUT
DELISTED
The WhiteWave Foods Company
WWAV
$29K ﹤0.01%
1,000
-600
-38% -$15.9K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.